top of page
THE NEED
When a communicable disease outbreak begins, the ideal response is for public health officials to begin testing for it early. That leads to quick identification of cases, quick treatment for those people and immediate isolation to prevent spread.
Testing can help people determine if they are infected with SARS-CoV-2, regardless of whether they have symptoms – and whether they are at risk of spreading the infection to others.
THE ADVANTAGE
The Virolens system employs a holographic microscope combined with artificial intelligence to determine whether the virus exists in the sample.
Virolens does not use chemical or biological testing, but rather identifies the unique diffraction patterns created by light interacting with virus surface proteins to identify COVID-19.
THE OPPORTUNITY
RAPID SCREENING SYSTEM
The Virolens system is a screening device that combines holographic microscopy with artificial intelligence to detect SARS.CoV.2, the virus that causes COVID-19 disease.
1
The Virolens system uses a mouth swab, which is placed inside a cartridge and inserted into the system. The Virolens system is a portable floor standing device.
2
Inside the system is a holographic microscope designed to look at nanoscale structures. Light is projected onto the slide creating identifiable diffraction patterns.
3
The holographic image data is analysed using Artificial Intelligence to identify the unique pattern of the virus from all of the other cells very quickly.
4
The Virolens system is completely self contained and can give a yes/no result in around 20 seconds with the whole process taking about a few minutes.
KEY ADVANTAGES
A new application of existing technologies
This is a brand new screening device which combines microscopic holographic imaging and artificial intelligence (AI) software technology.
Future proof software
The system can detect virus patterns as they evolve and change, meaning it will remain effective for years to come and can be used to test for new viruses if and when they appear.
A new application of existing technologies
An internal validation study by iAbra found that the Virolens system has a 98.1% sensitivity and 99.7% specificity.
Quick and easy testing
The system does not require a trained biologist to determine the results. It takes around 20 seconds to get a yes/no result.
Applicable to other diseases
Currently the system is only trained to look for and recognise COVID-19 but we are working to extend it to other diseases.
Able to collect anonymised data
The system collects anonymised data which can be interrogated to understand the spread of COVID-19 in testing areas.
bottom of page